Cargando…

Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients

The equivalence of intravenous push (IVP) and piggyback (IVPB) administration has not been evaluated in the critically ill population for most medications, but it is especially relevant for antibiotics, such as cefepime, that exhibit time-dependent bactericidal activity. A single center, retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Susan E., Halbig, Zachary, Fox, Nicholas R., Bland, Christopher M., Branan, Trisha N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295171/ https://www.ncbi.nlm.nih.gov/pubmed/37370315 http://dx.doi.org/10.3390/antibiotics12060996

Ejemplares similares

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

2562. Retrospective Analysis of Cefepime Intravenous Push versus Extended Infusion for the Treatment of Neutropenic Fever
por: Rust, Thomas J, et al.
Publicado: (2023)

Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
por: Khole, Aalok V., et al.
Publicado: (2023)

1306. Comparison of the Use of Extended and Intermittent Infusion Cefepime and Piperacillin/tazobactam in Non-critically Ill, Obese Patients
por: Marg, Carolyn, et al.
Publicado: (2020)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999)

Fluid Stewardship During Critical Illness: A Call to Action
por: Hawkins, W. Anthony, et al.
Publicado: (2019)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review
por: Hui, Ligia-Ancuta, et al.
Publicado: (2022)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
por: Naiim, Christina Medhat, et al.
Publicado: (2022)

602. Intravenous Push Versus Intravenous Piggyback Administration of Cephalosporin Antibiotics: Impact on Safety, Workflow, and Cost
por: Lee, Ryan, et al.
Publicado: (2021)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
por: Xu, Jinhui, et al.
Publicado: (2022)

2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negative (GN) Bacteremia
por: Tran, Kieu-Nhi, et al.
Publicado: (2019)

Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients
por: Beigmohammadi, Mohammad Taghi, et al.
Publicado: (2013)

Conversion from prolonged intravenous fentanyl infusion to enteral methadone in critically ill children
por: Srinivasan, Vijay, et al.
Publicado: (2017)

Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, A, et al.
Publicado: (2013)

Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, Adriana, et al.
Publicado: (2012)

Pushing the envelope to reduce sedation in critically ill patients
por: Ogundele, Olufunmilayo, et al.
Publicado: (2010)

Twelve Tips for Synergistic Delivery of Remote Advanced Pharmacy Practice Experience Rotations
por: Branan, Trisha, et al.
Publicado: (2020)

Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case–Control Study
por: Singh, Tarun D., et al.
Publicado: (2020)

1109. Pharmacokinetics and Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
por: Kois, Abigail K, et al.
Publicado: (2021)

Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022)

Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
por: Warda, Ahmed E. Abou, et al.
Publicado: (2022)

Eosinophilic pneumonia caused by cefepime: A case report and review
por: Jones, Bruce M., et al.
Publicado: (2021)

2687. Extended Infusions of Piperacillin/Tazobactam vs. Cefepime for Empiric Treatment of Neutropenic Fever
por: Norman, Sarah, et al.
Publicado: (2019)

Intravenous overload of fluids and sodium may contribute to the lower infusion of enteral nutrition in critically ill patients
por: Dock-Nascimento, Diana Borges, et al.
Publicado: (2019)

Impact of Intravenous Fluid Challenge Infusion Time on Macrocirculation and Endothelial Glycocalyx in Surgical and Critically Ill Patients
por: Pouska, Jiri, et al.
Publicado: (2018)

Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study
por: Cowan, Juthaporn, et al.
Publicado: (2020)

Association of hidden fluid administration with development of fluid overload reveals opportunities for targeted fluid minimization
por: Branan, Trisha, et al.
Publicado: (2020)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Population Pharmacokinetics and Monte Carlo Simulation of Cefepime in Critically Ill Patients with Hospital-Acquired/Ventilator-Associated Pneumonia
por: Seo, Hyeonji, et al.
Publicado: (2023)

60. Evaluation of Outcomes Associated with Intermittent Versus Extended Infusion of Piperacillin/tazobactam in Acutely Ill Veterans
por: Encarnacion, Marianne Angeli, et al.
Publicado: (2020)

Intermittent feeding and circadian rhythm in critical illness
por: Kouw, Imre W.K., et al.
Publicado: (2022)

Editorial: Intermittent feeding in critically ill patients
por: Deana, Cristian, et al.
Publicado: (2023)

Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia
por: Ibrahim, Mohamed M, et al.
Publicado: (2017)

The metabolic effects of intermittent versus continuous feeding in critically ill patients
por: Wilkinson, D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4b41n8qsm0ctma5m71338j9ppc